Carlson, Aaron M <br/><br/>
Utility of progranulin and serum leukocyte protease inhibitor as diagnostic and prognostic biomarkers in ovarian cancer.  [electronic resource] 

 -  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology  Oct 2013 
 - 1730-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-7755 
<br/><br/><label>Standard No.: </label>10.1158/1055-9965.EPI-12-1368  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--blood<br/>Carcinoma, Ovarian Epithelial<br/>Cohort Studies<br/>Female<br/>Humans<br/>Intercellular Signaling Peptides and Proteins--blood<br/>Leukocytes--metabolism<br/>Middle Aged<br/>Neoplasms, Glandular and Epithelial--blood<br/>Ovarian Neoplasms--blood<br/>Prognosis<br/>Progranulins<br/>Protease Inhibitors--blood<br/>Secretory Leukocyte Peptidase Inhibitor--blood<br/>Survival Analysis